Galvez: Covid-19 vaccine wastage ‘minimal’, ‘very negligible’ | Inquirer News

Galvez: Covid-19 vaccine wastage ‘minimal’, ‘very negligible’

By: - Reporter / @DYGalvezINQ
/ 05:55 PM March 16, 2021

MANILA, Philippines — COVID-19 vaccine wastage in the country is so far “minimal” and “very negligible,” vaccine czar Carlito Galvez Jr. said Tuesday.

For its COVID-19 vaccination program, the Philippines is so far using 600,000 doses developed by Chinese drugmaker Sinovac BioTech and 525,600 doses of British-Swede firm AstraZeneca vaccines.

So far, reported wastage of Sinovac doses were only instances of broken vials of shots while there were some extra or missing vials of AstraZeneca vaccines in packages, Galvez said.

ADVERTISEMENT

“Sa ngayon very minimal lang ang wastage, ‘yung mga wastage is more on sa extraction. So sa ngayon, nakita natin very negligible ‘yung wastage,” he said.

FEATURED STORIES

(As of now, the wastage is very minimal. It’s more on the extraction. For now, we can see that the wastage is negligible.)

A total of 216,794 medical frontliners have received vaccine doses against COVID-19 as of Tuesday, 11 a.m., Galvez said.

About 2.3 million more vaccine doses from Sinovac and AstraZeneca are expected to arrive in the country in late March or early April, he added.

JE
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: AstraZeneca, COVID-19, Sinovac, vaccine, wastage

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.